Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Safe Supply Announces Strategic Expansion into AI-Powered Healthcare Solutions (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Thallion Pharmaceuticals Inc V.TLN

Healthcare Biotechnology

Recent & Breaking News (TSXV:TLN)

Unit 1 at Susquehanna Nuclear Plant Returns to Service

PR Newswire May 3, 2016

Talen Energy Completes Sale of C.P. Crane Power Plant in Maryland

Press Releases February 16, 2016

Thallion Pharmaceuticals Announces Cash Component of $0.1889 Per Share

Marketwired August 9, 2013

Thallion Announces Shareholder Approval for Plan of Arrangement and Date and Time for the Motion for Final Court Order

Marketwired August 6, 2013

RETRANSMISSION/Thallion Pharmaceuticals Announces Minimum Effective Net Cash of $7,500,000 Resulting in Cash Component of at Least $0.1765 Per Share

Marketwired August 2, 2013

Thallion Pharmaceuticals Announces Minimum Effective Net Cash of $7,500,000 Resulting in Cash Component of at Least $0.1765 Per Share

Marketwired August 2, 2013

Thallion Announces 2013 Second Quarter Operating Results

Marketwired July 25, 2013

RETRANSMISSION: BELLUS Health Amends Terms of CVRs in Connection With Its Acquisition of Thallion

Marketwired July 12, 2013

BELLUS Health Amends Terms of CVRs in Connection With Its Acquisition of Thallion

Marketwired July 10, 2013

BELLUS Health Amends Terms of CVRs in Connection With Its Acquisition of Thallion

Marketwired July 10, 2013

IIROC Trading Resumption - TLN

Canada NewsWire July 3, 2013

IIROC Trade Resumption - Thallion Pharmaceuticals Inc.

Newsfile July 3, 2013

Thallion's Annual and Special Meeting to Be Held August 6, 2013

Marketwired July 2, 2013

Thallion's Annual and Special Meeting to Be Held August 6, 2013

Marketwired July 2, 2013

IIROC Trading Halt - TLN

Canada NewsWire July 2, 2013

IIROC Trade Halt - Thallion Pharmaceuticals Inc.

Newsfile July 2, 2013

Thallion Reaffirms Support of BELLUS Health Acquisition

Marketwired June 20, 2013

Thallion Reaffirms Support of BELLUS Health Acquisition

Marketwired June 20, 2013

Thallion Pharmaceuticals shares soar on takeover offer

Stockhouse Editorial June 18, 2013

Orbite Aluminae soars 30% on off-take agreement: Canadian market movers

Elizabeth Walters June 18, 2013